These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 1668604)

  • 21. Vasodilatory properties in vascular smooth muscle of the calcium antagonist NB-818 compared to nicardipine and nimodipine.
    Nishikibe M; Fukuroda T; Nakajima A
    Arch Int Pharmacodyn Ther; 1989; 297():98-111. PubMed ID: 2730244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644.
    Schramm M; Towart R; Kazda S; Thomas G; Franckowiak G
    Adv Myocardiol; 1985; 6():59-70. PubMed ID: 2581301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ryodipine on electromechanical parameters of heart and vessels, cAMP phosphodiesterase activity and swelling-contraction cycle of mitochondria.
    Velena AH; Dubur GJ; Vitolina RO; Kimenis AA; Selga MJ; Zarinsh GV; Narusevicius EV; Macianskiene RA; Gendvilienè VI; Simkhovich BZ
    Arzneimittelforschung; 1985; 35(6):907-14. PubMed ID: 2992533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of S-312, a new calcium antagonist, on the mechanical and electrophysiological responses of isolated cardiovascular preparations.
    Ninomiya M; Tani T; Nakajima S; Ueda M
    Jpn J Pharmacol; 1989 Oct; 51(2):227-38. PubMed ID: 2593380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium blocking properties of piprofurol.
    Pourrias B; Huerta F; Santamaria R; Bowe C
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):223-39. PubMed ID: 4026458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
    Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
    Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
    Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P
    J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
    Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
    Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LY249933: a cardioselective 1,4-dihydropyridine with positive inotropic activity.
    Holland DR; Wikel JH; Kauffman RF; Smallwood JK; Zimmerman KM; Utterback BG; Turk JA; Steinberg MI
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):483-91. PubMed ID: 2476630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular effects of the new dihydropyridine derivative elgodipine.
    Tamargo J; López-Sendón J; Delpón E; González-Morales M; de Miguel E
    Arzneimittelforschung; 1991 Sep; 41(9):895-900. PubMed ID: 1796916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intervessel (arteries and veins) and heart/vessel selectivities of therapeutically used calcium entry blockers: variable, vessel-dependent indexes.
    Magnon M; Gallix P; Cavero I
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1157-66. PubMed ID: 8531077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged depolarization increases the pharmacological effect of dihydropyridines and their binding affinity for calcium channels of vascular smooth muscle.
    Morel N; Godfraind T
    J Pharmacol Exp Ther; 1987 Nov; 243(2):711-5. PubMed ID: 2824756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule.
    Thomas G; Gross R; Schramm M
    J Cardiovasc Pharmacol; 1984; 6(6):1170-6. PubMed ID: 6084776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nicardipine actions on smooth muscle cells and neuromuscular transmission in the guinea-pig basilar artery.
    Fujiwara S; Kuriyama H
    J Pharmacol Exp Ther; 1983 May; 225(2):447-55. PubMed ID: 6302249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological characteristics of NP-252, a new dihydropyridine slow Ca2+ channel blocker, in isolated rabbit vascular smooth muscle and guinea pig myocardium: vascular selectivity.
    Shibata S; Satake N; Kodama I; Hester RK; Wang CG; Jino H; Hojo M; Tatsumi H; Gandhi V; Jones DJ
    Eur J Pharmacol; 1991 Oct; 203(3):337-44. PubMed ID: 1773820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of a newly synthesized dihydropyridine, NZ-105, on intracellular Ca transients and tension in ferret ventricular muscles.
    Kurihara S; Hongo K; Tanaka T; Tanaka E
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):274-80. PubMed ID: 7526060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
    Kanda M; Shirahase H; Kurahashi K; Wada K; Nakamura S; Matsui H; Fukata F
    Arzneimittelforschung; 1995 Aug; 45(8):831-5. PubMed ID: 7575741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of calcium antagonists and agonists on isolated human v. saphena magna used for coronary artery bypass grafting and guinea pig's papillary muscle.
    Garaliene V; Barsys V; Jakuska P; Krauze A; Duburs G
    Arzneimittelforschung; 2011; 61(7):386-92. PubMed ID: 21899206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro assessment for vascular selectivity of a new dihydropyridine derivative, NB-818.
    Hattori Y; Fukao M; Houzen H; Qi F; Yamada Y; Kanno M
    Eur J Pharmacol; 1996 Apr; 301(1-3):99-106. PubMed ID: 8773452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.